Clinical Efficacy of a Novel Therapeutic Principle, Anakoinosis

Classic tumor therapy, consisting of cytotoxic agents and/or targeted therapy, has not overcome therapeutic limitations like poor risk genetic parameters, genetic heterogeneity at different metastatic sites or the problem of undruggable targets. Here we summarize data and trials principally followin...

Descripción completa

Detalles Bibliográficos
Autores principales: Heudobler, Daniel, Rechenmacher, Michael, Lüke, Florian, Vogelhuber, Martin, Klobuch, Sebastian, Thomas, Simone, Pukrop, Tobias, Hackl, Christina, Herr, Wolfgang, Ghibelli, Lina, Gerner, Christopher, Reichle, Albrecht
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279883/
https://www.ncbi.nlm.nih.gov/pubmed/30546308
http://dx.doi.org/10.3389/fphar.2018.01357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279883/
https://www.ncbi.nlm.nih.gov/pubmed/30546308
http://dx.doi.org/10.3389/fphar.2018.01357

Ejemplares similares